THIS GSK UPDATE CLARIFIES LEGAL QUESTIONS REGARDING THE CORONAVIRUS PANDEMIC WITH RESPECT TO THE TOPICS OF CONTRACTUAL OBLIGATIONS, CONTRACT ADJUSTMENT AND TERMINATION AS WELL AS ON LEGISLATIVE CHANGES. POSSIBLE CLAIMS AGAINST INSURANCE COMPANIES AND THE STATE ARE ALSO DISCUSSED.
Pacta sunt servanda in times of crisis? We answer legal questions concerning the fulfilment of contractual relationships. Read our GSK update on the coronavirus pandemic now.
Press contact
presse@gsk.de
+49 30 203907-7763
Dr. Justus Jansen
Partner*
+49 40 369703-62
justus.jansen@gsk.de
Dr. Antonius Jonetzki
Partner*
+49 40 369703-62
antonius.jonetzki@gsk.de
Dr. Markus Söhnchen
Partner*
+49 69 71003-0
markus.soehnchen@gsk.de
Dr. Katy Ritzmann
Partner*
+49 30 203907-422
katy.ritzmann@gsk.de
Dr. Thomas Derlin, LL. M. (Sydney)
Partner*
+49 30 203907-0
thomas.derlin@gsk.de
Dr. Jens Uwe Rügenhagen
Partner*
+49 6221 4566-12
jens.ruegenhagen@gsk.de
Dr. Marcel Vietor
Partner*
+49 89 288174-74
marcel.vietor@gsk.de
For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.
